Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $549,891 | 240 | 72.0% |
| Travel and Lodging | $94,433 | 325 | 12.4% |
| Consulting Fee | $80,185 | 22 | 10.5% |
| Food and Beverage | $38,265 | 1,042 | 5.0% |
| Education | $799.04 | 14 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $471,645 | 663 | $0 (2024) |
| Gilead Sciences, Inc. | $170,424 | 455 | $0 (2024) |
| Janssen Products, LP | $111,856 | 132 | $0 (2022) |
| Merck Sharp & Dohme LLC | $2,345 | 72 | $0 (2024) |
| Janssen Biotech, Inc. | $1,517 | 92 | $0 (2023) |
| ABBVIE INC. | $1,021 | 43 | $0 (2024) |
| Theratechnologies Inc. | $788.61 | 28 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $687.61 | 8 | $0 (2019) |
| GlaxoSmithKline, LLC. | $672.07 | 15 | $0 (2024) |
| Napo Pharmaceuticals Inc | $525.91 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $132,423 | 263 | ViiV Healthcare Company ($115,275) |
| 2023 | $121,964 | 264 | ViiV Healthcare Company ($111,163) |
| 2022 | $103,881 | 197 | ViiV Healthcare Company ($81,458) |
| 2021 | $62,274 | 196 | ViiV Healthcare Company ($47,485) |
| 2020 | $45,583 | 122 | ViiV Healthcare Company ($29,636) |
| 2019 | $117,571 | 246 | ViiV Healthcare Company ($57,570) |
| 2018 | $84,549 | 177 | Gilead Sciences, Inc. ($36,219) |
| 2017 | $95,329 | 178 | Janssen Products, LP ($50,960) |
All Payment Transactions
1,643 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: HIV | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: HIV | ||||||
| 12/18/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $28.92 | General |
| Category: Infectious Disease | ||||||
| 12/18/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: HIV | ||||||
| 12/12/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: HIV | ||||||
| 12/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/10/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $117.52 | General |
| 12/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $133.99 | General |
| 12/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: HIV | ||||||
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: HIV | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $31.72 | General |
| 11/13/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.62 | General |
| 11/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| Category: HIV | ||||||
| 11/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $365.79 | General |
| Category: HIV | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.03 | General |
| 11/07/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: HIV | ||||||
| 11/05/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 892 | 1,134 | $409,115 | $65,703 |
| 2022 | 9 | 319 | 530 | $169,732 | $32,999 |
| 2021 | 13 | 357 | 472 | $123,248 | $25,241 |
| 2020 | 4 | 145 | 215 | $34,712 | $9,770 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 291 | $137,594 | $22,328 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 131 | $41,628 | $7,310 | 17.6% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 36 | 36 | $27,000 | $4,625 | 17.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 49 | 49 | $8,575 | $3,715 | 43.3% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 44 | 44 | $28,600 | $3,123 | 10.9% |
| 93882 | Ultrasound of one side of head and neck blood flow | Office | 2023 | 35 | 35 | $26,250 | $2,742 | 10.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $7,370 | $2,685 | 36.4% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 41 | 41 | $20,500 | $2,501 | 12.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $12,060 | $2,494 | 20.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 46 | 47 | $28,200 | $2,265 | 8.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $10,795 | $2,185 | 20.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 52 | $2,600 | $1,593 | 61.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $8,190 | $1,561 | 19.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 36 | 36 | $7,200 | $1,471 | 20.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 41 | 41 | $8,200 | $835.17 | 10.2% |
| 92250 | Photography of the retina | Office | 2023 | 29 | 29 | $11,600 | $793.52 | 6.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 41 | 41 | $4,510 | $785.97 | 17.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 41 | 41 | $6,970 | $736.36 | 10.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 18 | 18 | $1,620 | $735.48 | 45.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 47 | $3,760 | $460.96 | 12.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 37 | $3,694 | $363.80 | 9.8% |
| 90471 | Administration of vaccine | Office | 2023 | 15 | 18 | $1,655 | $199.16 | 12.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $543.00 | $193.05 | 35.6% |
| 91312 | Sarscov2 vac bvl 30mcg/0.3ml | Office | 2023 | 19 | 19 | $0.19 | $0.19 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 244 | $115,118 | $20,237 | 17.6% |
About Dr. Marc Tribble, M.D
Dr. Marc Tribble, M.D is a Specialist healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982669883.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Tribble, M.D has received a total of $763,573 in payments from pharmaceutical and medical device companies, with $132,423 received in 2024. These payments were reported across 1,643 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($549,891).
As a Medicare-enrolled provider, Tribble has provided services to 1,713 Medicare beneficiaries, totaling 2,351 services with total Medicare billing of $133,712. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Infectious Disease, Internal Medicine
- Location Dallas, TX
- Active Since 04/20/2006
- Last Updated 08/03/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1982669883
Products in Payments
- DOVATO (Drug) $314,038
- CABENUVA (Biological) $94,364
- Epclusa (Drug) $57,091
- PREZCOBIX (Drug) $35,339
- Biktarvy (Drug) $31,385
- Symtuza (Drug) $25,999
- SYMTUZA (Drug) $11,889
- TIVICAY (Drug) $9,070
- Descovy (Drug) $4,690
- Genvoya (Drug) $4,522
- Vosevi (Drug) $4,142
- APRETUDE (Biological) $1,281
- TRIUMEQ (Drug) $923.73
- PIFELTRO (Drug) $696.39
- ISENTRESS (Drug) $588.64
- Mytesi (Drug) $525.91
- EGRIFTA (Drug) $480.60
- JULUCA (Drug) $468.24
- DELSTRIGO (Drug) $453.08
- VRAYLAR (Drug) $351.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Dallas
Dr. William Lumry, M.d, M.D
Specialist — Payments: $2.4M
Dr. Roy Fleischmann, M.d, M.D
Specialist — Payments: $1.6M
Stephen Hohmann, Md, MD
Specialist — Payments: $551,635
Dr. William Adams, M.d, M.D
Specialist — Payments: $350,194
Clinton Bell, M.d, M.D
Specialist — Payments: $273,947
Dennis Gable, Md, MD
Specialist — Payments: $243,097